|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date30 Jun 1987 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 May 1975 |
100 Clinical Results associated with Auro Pharma, Inc.
0 Patents (Medical) associated with Auro Pharma, Inc.
100 Deals associated with Auro Pharma, Inc.
100 Translational Medicine associated with Auro Pharma, Inc.